All News

in Other News

Physiomics is delighted to announce the publication by Springer of the book ‘Cancer Systems Biology, Bioinformatics and Medicine’ in the Research and Clinical Applications series. Physiomics’ scientists have written the chapter 14 entitled “Systems biology approaches to cancer drug development.” “This teaching monograph on systems approaches to cancer research and clinical applications provides a unique synthesis, by world-class scientists and doctors, of laboratory, computational, and clinical...

24 Jun

Physiomics is recruiting a Web and Database developer (Updated)

in Other News

The Web Developer will be responsible for creation and design of a database and web interface according to specification. Please read our career section for a detailed description. Update: the position has now been filled....

25 May

AACR 2011 posters available for download

in Other News

The two posters that have been presented at the AACR 102nd Annual Meeting 2011, taking place in the Orange County Convention Center, Orlando, Florida on 2-6 April 2011, are now available for download. The poster titled "Predicting the effect of combination schedules on xenograft tumor using the Virtual Tumor" presents the validation of our Virtual Tumour platform, which was completed in collaboration with the global...

04 May

New Collaboration with Pharmacometrics Limited

Physiomics (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce the execution of a new collaboration agreement with Pharmacometrics Limited ("Pharmacometrics"), pursuant to which it is agreed that both parties will work together to develop an anti-cancer drug regimen and combination database. Read more...

06 Apr

Completion of Placing

The Company announces that it has raised £600,000 from the issue of 120,000,000 new ordinary shares of 0.04p each ("Ordinary Shares") at a price of 0.5p per share, by way of a placing through WH Ireland Limited (the "Placing"). Application has been made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 12 April 2011. Read...

05 Apr

AACR Poster on Lilly Collaboration

in Other News

Physiomics (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it will be participating in the AACR 102nd Annual Meeting 2011, taking place in the Orange County Convention Center, Orlando, Florida on 2-6 April 2011. Dr Eric Fernandez, Project Leader at Physiomics, will present on a validation of our Virtual Tumour platform, which was completed in collaboration with Eli Lilly...

01 Apr

Results Update – Virtual Tumour

Physiomics (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that positive results have been generated in a pre-clinical in-vivo study into breast cancer based on the Company’s “Virtual Tumour” model predictions. The directors believe these results provide further validation as to the predictive capability of the Company’s technology. Read more...

06 Dec

Appointment of an Executive Director

Physiomics (AIM: PYC), the Oxford, UK, based systems biology company, is pleased to announce the appointment of Dr Mark Chadwick as Chief Executive Officer of the Company. As a Director of the Company he will join the main Board and the Remuneration Committee. Read more ...

15 Nov

Carbon Trust Grant